Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Signs and symptoms preceding acute attacks of hereditary angioedema: results of three recent surveys.

Reshef A, Prematta MJ, Craig TJ.

Allergy Asthma Proc. 2013 May-Jun;34(3):261-6. doi: 10.2500/aap.2013.34.3663.

PMID:
23676575
2.

Per-attack reporting of prodromal symptoms concurrent with C1-inhibitor treatment of hereditary angioedema attacks.

Prematta MJ, Bewtra AK, Levy RJ, Wasserman RL, Jacobson KW, Machnig T, Craig TJ.

Adv Ther. 2012 Oct;29(10):913-22. doi: 10.1007/s12325-012-0053-5. Epub 2012 Sep 27.

PMID:
23054691
3.

Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks.

Prematta MJ, Kemp JG, Gibbs JG, Mende C, Rhoads C, Craig TJ.

Allergy Asthma Proc. 2009 Sep-Oct;30(5):506-11. doi: 10.2500/aap.2009.30.3279.

PMID:
19843405
4.

Characterization of prodromal symptoms in a large population of patients with hereditary angio-oedema.

Magerl M, Doumoulakis G, Kalkounou I, Weller K, Church MK, Kreuz W, Maurer M.

Clin Exp Dermatol. 2014 Apr;39(3):298-303. doi: 10.1111/ced.12285.

PMID:
24635064
5.

Variability of prodromal signs and symptoms associated with hereditary angioedema attacks: a literature review.

Kemp JG, Craig TJ.

Allergy Asthma Proc. 2009 Sep-Oct;30(5):493-9. doi: 10.2500/aap.2009.30.3278. Review.

PMID:
19843403
6.

Content validity of visual analog scales to assess symptom severity of acute angioedema attacks in adults with hereditary angioedema: an interview study.

McMillan CV, Speight J, Relan A, Bellizzi L, Haase G, Cicardi M.

Patient. 2012;5(2):113-26. doi: 10.2165/11597490-000000000-00000.

PMID:
22462765
7.

Current characteristics associated with hereditary angioedema attacks and treatment: the home infusion based patient experience.

Tachdjian R, Banerji A, Guyer A, Morphew T.

Allergy Asthma Proc. 2015 Mar-Apr;36(2):151-9. doi: 10.2500/aap.2015.36.3832.

PMID:
25715244
8.

Quantifying the burden of disease and perceived health state in patients with hereditary angioedema in Sweden.

Nordenfelt P, Dawson S, Wahlgren CF, Lindfors A, Mallbris L, Björkander J.

Allergy Asthma Proc. 2014 Mar-Apr;35(2):185-90. doi: 10.2500/aap.2014.35.3738. Epub 2014 Jan 9.

PMID:
24411585
9.

The Turkish Hereditary Angioedema Pilot Study (TURHAPS): the first Turkish series of hereditary angioedema.

Kesim B, Uyguner ZO, Gelincik A, Mete Gökmen N, Sin AZ, Karakaya G, Erdenen F, Ardeniz O, Ozşeker F, Gülbahar O, Colakoğlu B, Dal M, Büyüköztürk S.

Int Arch Allergy Immunol. 2011;156(4):443-50. doi: 10.1159/000323915. Epub 2011 Aug 10. Erratum in: Int Arch Allergy Immunol. 2011;156(4):450.

PMID:
21832835
10.

Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies.

Bonner N, Abetz-Webb L, Renault L, Caballero T, Longhurst H, Maurer M, Christiansen S, Zuraw B; Icatibant Outcome Survey (IOS) International Executive Committee and the Hereditary Angioedema Association (HAEA) Medical Advisory Board.

Health Qual Life Outcomes. 2015 Jul 1;13:92. doi: 10.1186/s12955-015-0292-7.

11.

Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.

Craig TJ, Bewtra AK, Hurewitz D, Levy R, Janss G, Jacobson KW, Packer F, Bernstein JA, Rojavin MA, Machnig T, Keinecke HO, Wasserman RL.

Allergy Asthma Proc. 2012 Jul-Aug;33(4):354-61. doi: 10.2500/aap.2012.33.3589.

PMID:
22856636
12.

Economic costs associated with acute attacks and long-term management of hereditary angioedema.

Wilson DA, Bork K, Shea EP, Rentz AM, Blaustein MB, Pullman WE.

Ann Allergy Asthma Immunol. 2010 Apr;104(4):314-20. doi: 10.1016/j.anai.2010.01.024.

PMID:
20408341
13.

Efficacy and safety of ecallantide in treatment of recurrent attacks of hereditary angioedema: open-label continuation study.

Lumry WR, Bernstein JA, Li HH, MacGinnitie AJ, Riedl M, Soteres DF, Craig TJ, Campion M, Iarrobino R, Stolz LE, Pullman WE.

Allergy Asthma Proc. 2013 Mar-Apr;34(2):155-61. doi: 10.2500/aap.2013.34.3653. Erratum in: Allergy Asthma Proc. 2013 May-Jun;34(3):291.

PMID:
23484891
14.

Current state of hereditary angioedema management: a patient survey.

Banerji A, Busse P, Christiansen SC, Li H, Lumry W, Davis-Lorton M, Bernstein JA, Frank M, Castaldo A, Long JF, Zuraw BL, Riedl M.

Allergy Asthma Proc. 2015 May-Jun;36(3):213-7. doi: 10.2500/aap.2015.36.3824.

15.

Leukocytosis and high hematocrit levels during abdominal attacks of hereditary angioedema.

Ohsawa I, Nagamachi S, Suzuki H, Honda D, Sato N, Ohi H, Horikoshi S, Tomino Y.

BMC Gastroenterol. 2013 Aug 2;13:123. doi: 10.1186/1471-230X-13-123.

16.

Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks.

Grant JA, White MV, Li HH, Fitts D, Kalfus IN, Uknis ME, Lumry WR.

Allergy Asthma Proc. 2012 Jul-Aug;33(4):348-53. doi: 10.2500/aap.2012.33.3585.

PMID:
22856635
17.

Analysis of hereditary angioedema attacks requiring a second dose of ecallantide.

Li HH, Campion M, Craig TJ, Soteres DF, Riedl M, Lumry WR, MacGinnitie AJ, Shea EP, Bernstein JA.

Ann Allergy Asthma Immunol. 2013 Mar;110(3):168-72. doi: 10.1016/j.anai.2012.12.004. Epub 2013 Jan 8.

PMID:
23548526
18.

Use of ecallantide in pediatric hereditary angioedema.

MacGinnitie AJ, Davis-Lorton M, Stolz LE, Tachdjian R.

Pediatrics. 2013 Aug;132(2):e490-7. doi: 10.1542/peds.2013-0646. Epub 2013 Jul 22.

19.

The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression.

Lumry WR, Castaldo AJ, Vernon MK, Blaustein MB, Wilson DA, Horn PT.

Allergy Asthma Proc. 2010 Sep-Oct;31(5):407-14. doi: 10.2500/aap.2010.31.3394.

PMID:
20929608
20.

Treatment of hereditary angioedema with icatibant: efficacy in clinical trials versus effectiveness in the real-world setting.

Maurer M, Longhurst HJ, Fabien V, Li HH, Lumry WR.

Allergy Asthma Proc. 2014 Sep-Oct;35(5):377-81. doi: 10.2500/aap.2014.35.3780. Epub 2014 Aug 6.

PMID:
25198193
Items per page

Supplemental Content

Write to the Help Desk